MAPT and Alzheimer disease: Anti-amyloid therapies have frequently failed to deliver meaningful clinical benefits, and the hypothesis does not fully account for other pathological features of AD, such as tau hyperphosphorylation, which leads to the formation of neurofibrillary tangles, another key hallmark of AD pathology.